Gut Microbiome Composition and Its Metabolites Are a Key Regulating Factor for Malignant Transformation, Metastasis and Antitumor Immunity
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065978 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Stefan Lozenov und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Control and Monitoring of the Antibiotic Resistance, National Centre for Infectious and Parasitic Diseases, 26 Yanko Sakazov Blvd, 150…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Microbiota. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education and Science, Ministry of Education and Science of Bulgaria.
Abstract (Originalsprache)
The genetic and metabolomic abundance of the microbiome exemplifies that the microbiome comprises a more extensive set of genes than the entire human genome, which justifies the numerous metabolic and immunological interactions between the gut microbiota, macroorganisms and immune processes. These interactions have local and systemic impacts that can influence the pathological process of carcinogenesis. The latter can be promoted, enhanced or inhibited by the interactions between the microbiota and the host. This review aimed to present evidence that interactions between the host and the gut microbiota might be a significant exogenic factor for cancer predisposition. It is beyond doubt that the cross-talk between microbiota and the host cells in terms of epigenetic modifications can regulate gene expression patterns and influence cell fate in both beneficial and adverse directions for the host’s health. Furthermore, bacterial metabolites could shift pro- and anti-tumor processes in one direction or another. However, the exact mechanisms behind these interactions are elusive and require large-scale omics studies to better understand and possibly discover new therapeutic approaches for cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory for Control and Monitoring of the Antibiotic Resistance, National Centre for Infectious and Parasitic Diseases, 26 Yanko Sakazov Blvd, 1504 Sofia, Bulgaria.
- Nadezhda Paradise Medical Center, 1330 Sofia, Bulgaria.
- Department of Cell and Developmental Biology, Faculty of Biology, Sofia University "St. Kliment Ohridski", 1504 Sofia, Bulgaria.
- Department of Gastroenterology, University Hospital Lozenetz, Sofia, Medical Faculty, Sofia University "St. Kliment Ohridski", 1407 Sofia, Bulgaria.
- Department of Gastroenterology, University Hospital Heart and Brain, 5804 Pleven, Bulgaria.
- Medical Faculty, Sofia University St. Kliment Ohridski, Kozyak 1 str., 1407 Sofia, Bulgaria.
ORCID-Profile: Boris Krastev, Monika Peshevska-Sekulovska, Milena Peruhova, Tsvetelina Velikova
Förderung
- Ministry of Education and Science
- Ministry of Education and Science of Bulgaria
Zitieren
APA
Lozenov, S., Krastev, B., Nikolaev, G., Peshevska-Sekulovska, M., Peruhova, M., & Velikova, T. (2023). Gut Microbiome Composition and Its Metabolites Are a Key Regulating Factor for Malignant Transformation, Metastasis and Antitumor Immunity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065978
Vancouver
Lozenov S, Krastev B, Nikolaev G, Peshevska-Sekulovska M, Peruhova M, Velikova T. Gut Microbiome Composition and Its Metabolites Are a Key Regulating Factor for Malignant Transformation, Metastasis and Antitumor Immunity. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065978
BibTeX
@article{Lozenov2023,
author = {Lozenov, Stefan and Krastev, Boris and Nikolaev, Georgi and Peshevska-Sekulovska, Monika and Peruhova, Milena and Velikova, Tsvetelina},
title = {Gut Microbiome Composition and Its Metabolites Are a Key Regulating Factor for Malignant Transformation, Metastasis and Antitumor Immunity},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065978}
}
EUVIMED